J, S., M, P., LR, Y., V, V., M, B., M, A., . . . RD, B. (2024). Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers. Metabolomics : Official journal of the Metabolomic Society, 21(1), 3. https://doi.org/10.1007/s11306-024-02195-y
Chicago Style (17th ed.) CitationJ, Sun, et al. "Untargeted Metabolomics and Lipidomics in COVID-19 Patient Plasma Reveals Disease Severity Biomarkers." Metabolomics : Official Journal of the Metabolomic Society 21, no. 1 (2024): 3. https://doi.org/10.1007/s11306-024-02195-y.
MLA (9th ed.) CitationJ, Sun, et al. "Untargeted Metabolomics and Lipidomics in COVID-19 Patient Plasma Reveals Disease Severity Biomarkers." Metabolomics : Official Journal of the Metabolomic Society, vol. 21, no. 1, 2024, p. 3, https://doi.org/10.1007/s11306-024-02195-y.